rs10853869
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_015629.4(PRPF31):c.946-351G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.311 in 151,936 control chromosomes in the GnomAD database, including 7,646 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.31 ( 7646 hom., cov: 33)
Consequence
PRPF31
NM_015629.4 intron
NM_015629.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.21
Publications
10 publications found
Genes affected
PRPF31 (HGNC:15446): (pre-mRNA processing factor 31) This gene encodes a component of the spliceosome complex and is one of several retinitis pigmentosa-causing genes. When the gene product is added to the spliceosome complex, activation occurs.[provided by RefSeq, Jan 2009]
PRPF31 Gene-Disease associations (from GenCC):
- PRPF31-related retinopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- retinitis pigmentosa 11Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.382 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PRPF31 | NM_015629.4 | c.946-351G>A | intron_variant | Intron 9 of 13 | ENST00000321030.9 | NP_056444.3 | ||
| PRPF31 | XM_006723137.5 | c.946-351G>A | intron_variant | Intron 9 of 13 | XP_006723200.1 | |||
| PRPF31 | XM_047438587.1 | c.974-351G>A | intron_variant | Intron 9 of 9 | XP_047294543.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.310 AC: 47130AN: 151820Hom.: 7625 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
47130
AN:
151820
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.311 AC: 47190AN: 151936Hom.: 7646 Cov.: 33 AF XY: 0.308 AC XY: 22863AN XY: 74258 show subpopulations
GnomAD4 genome
AF:
AC:
47190
AN:
151936
Hom.:
Cov.:
33
AF XY:
AC XY:
22863
AN XY:
74258
show subpopulations
African (AFR)
AF:
AC:
16030
AN:
41456
American (AMR)
AF:
AC:
5003
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
1096
AN:
3472
East Asian (EAS)
AF:
AC:
324
AN:
5130
South Asian (SAS)
AF:
AC:
1386
AN:
4794
European-Finnish (FIN)
AF:
AC:
3012
AN:
10570
Middle Eastern (MID)
AF:
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
AC:
19396
AN:
67936
Other (OTH)
AF:
AC:
679
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1667
3334
5000
6667
8334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
462
924
1386
1848
2310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
799
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.